KIM
RVMD icon

Kestra Investment Management’s Revolution Medicines RVMD Stock Holding History

Kestra Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-352
Closed -$12.7K – 891
2025
Q2 		$12.7K Buy
352
+184
+110% +$7.07K ﹤0.01% 683
2025
Q1 		$5.94K Buy
+168
New +$6.82K ﹤0.01% 668

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kestra Investment Management's RVMD Position: Q3 2025 in Review

Kestra Investment Management sold out of Revolution Medicines (RVMD) in Q3 2025, closing a stake of 352 shares — an estimated $12.7K sold.

Kestra Investment Management first reported a position in RVMD in Q1 2025 and held it in 2 quarters. The position peaked at $12.7K in Q2 2025. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Kestra Investment Management reported no remaining Revolution Medicines position as of Q3 2025 after selling out during the quarter.
  • Kestra Investment Management sold 352 Revolution Medicines shares in Q3 2025, an estimated $12.7K.
  • Kestra Investment Management first reported a position in Revolution Medicines in Q1 2025 and held it in 2 quarters.
  • Kestra Investment Management's Revolution Medicines position peaked at $12.7K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Kestra Investment Management's 13F filing for Q3 2025, filed 17 Nov 2025.